Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04301414
Title Non-fucosylated Anti-CTLA-4 (BMS-986218) + Degarelix Acetate vs. Degarelix Acetate Alone in Men With High-risk Localized Prostate Cancer (Neo-Red-P)
Acronym Neo-Red-P
Recruitment Active, not recruiting
Gender male
Phase Phase I
Variant Requirements No
Sponsors Charles G. Drake
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.